Anaesthesia for patients with mood disorders
- 1 June 2005
- journal article
- anaesthesia and-medical-disease
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion In Anesthesiology
- Vol. 18 (3), 333-338
- https://doi.org/10.1097/01.aco.0000169243.03754.85
Abstract
Purpose of review Treatment of patients with mood disorders has changed over the past few years. It is not always clear how the anaesthesiologist has to incorporate these antidepressants and mood stabilizers in premedication or even how to anticipate any interaction with anaesthetic technique. Recent findings The older generation of antidepressants (tricyclic antidepressants, monoamine oxidase inhibitors) is seldom used nowadays. Actually, treatment with selective serotonin-reuptake inhibitors, serotonin noradrenalin-reuptake inhibitors, noradrenaline-reuptake inhibitor, noradrenergic and specific serotonin antidepressants, or noradrenaline- and dopamine-reuptake inhibitors is common practice. Combination with atypical antipsychotics and newer antiepileptics is suggested as an add-on therapy or as monotherapy, while lithium and valproate therapy is still the first choice in bipolar mood stabilization. Electroconvulsive therapy is still used in therapy-resistant forms of depression; however, the anaesthesia technique herein has been increasingly well described in the last years. Electroencephalogram-derived monitoring such as bispectral index (BIS) can be used as a tool to predict seizure duration. Intoxications with these newer agents are not infrequent and deserve specific attention. In particular, serotonin syndrome is a life-threatening condition that requires great care by the anaesthesiologist. The chronic use of antidepressants does affect the anaesthetized patient: hypotension, arrhythmias, changed thermoregulation, altered postoperative pain, differences in surgical stress response and postoperative confusion. However, it is advised to continue these drugs in the perioperative period. Summary Discontinuation of treatment with the new antidepressants in the perioperative period is not advised. Intoxication with the newer drugs appears to be safer. The anaesthesiologist must pay attention to serotonin syndrome. Electroconculsive therapy has gained renewed attention.Keywords
This publication has 31 references indexed in Scilit:
- Antidepressants and suicidal behaviour in unipolar depressionActa Psychiatrica Scandinavica, 2004
- The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in EuropeActa Psychiatrica Scandinavica, 2004
- Anesthetic considerations of the herbal, kavaJournal of Clinical Anesthesia, 2004
- Relapse into mania or depression following lithium discontinuation: a 7‐year follow‐upActa Psychiatrica Scandinavica, 2004
- Chronic Treatment with Antipsychotics Enhances Intraoperative Core HypothermiaAnesthesia & Analgesia, 2004
- Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial InfarctionDrug Safety, 2004
- Chronic Treatment with Antidepressants Decreases Intraoperative Core HypothermiaAnesthesia & Analgesia, 2003
- Switch to Mania upon Discontinuation of Antidepressants in Patients with Mood Disorders: A Review of the LiteratureThe Canadian Journal of Psychiatry, 2003
- Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexineCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2003
- Antidepressant treatment for chronic depressed patients should not be discontinued prior to anesthesiaCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2002